NASDAQ

Editas Medicine, Inc. (EDIT)

♥ 652 Thanks from members

Live price chart, market sentiment, and community perspectives for Editas Medicine, Inc. (NASDAQ: EDIT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Feng ZhangFounder: David LiuFounder: George ChurchFounder: J. Keith JoungFounder: Jonghwan KimLeadership: Vikram Rao (CEO)Holder: FMR LLCHolder: Vanguard GroupHolder: BlackRock Inc.Holder: Polaris PartnersEDIT-101EDIT-301CRISPR gene editing therapeutics#EDIT stock#Editas Medicine#CRISPR therapeutics#Gene editing biotech#NASDAQ EDIT